The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Antiviral Therapy and Outcomes of Influenza Requiring Hospitalization in Ontario, Canada
Abstract
BACKGROUND: We conducted a prospective cohort study to assess the impact of antiviral therapy on outcomes of patients hospitalized with influenza in southern Ontario, Canada. METHODS: Patients admitted to Toronto Invasive Bacterial Diseases Network hospitals with laboratory-confirmed influenza from 1 January 2005 through 31 May 2006 were enrolled in the study. Demographic and medical data were collected by patient and physician interview and chart review. The main outcome evaluated was death within 15 days after symptom onset. RESULTS: Data were available for 512 of 541 eligible patients. There were 185 children (<15 years of age), none of whom died and none of whom were treated with antiviral drugs. The median age of the 327 adults was 77 years (range, 15-98 years), 166 (51%) were male, 245 (75%) had a chronic underlying illness, and 216 (71%) had been vaccinated against influenza. Of the 327 adult patients, 184 (59%) presented to the emergency department within 48 h after symptom onset, 52 (16%) required intensive care unit admission, and 27 (8.3%) died within 15 days after symptom onset. Most patients (292 patients; 89%) received antibacterial therapy; 106 (32%) were prescribed antiviral drugs. Treatment with antiviral drugs active against influenza was associated with a significant reduction in mortality (odds ratio, 0.21; 95% confidence interval, 0.06-0.80; n=100, 260). There was no apparent impact of antiviral therapy on length of stay in survivors. CONCLUSIONS: There is a significant burden of illness attributable to influenza in this highly vaccinated population. Treatment with antiviral drugs was associated with a significant reduction in mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Influenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213
Neuraminidase Inhibitors for Influenza
Moscona, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050740 · Cited by 1,094
The Underrecognized Burden of Influenza in Young Children
Poehling, K. A., Edwards, K. M., Weinberg, G. A., Szilagyi, P., Staat, M. A., Iwane, M. K., Bridges, C. B., Grijalva, C. G., Zhu, Y., Bernstein, D. I., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054869 · Cited by 872
Govaert, T. M. E. (1994) · JAMA · doi:10.1001/jama.1994.03520210045030 · Cited by 867
Kinetics of Influenza A Virus Infection in Humans
Baccam, P., Beauchemin, C., Macken, C. A., Hayden, F. G., & Perelson, A. S. (2006) · Journal of Virology · doi:10.1128/jvi.01623-05 · Cited by 756
Clinical signs and symptoms predicting influenza infection
Monto, A. S., Gravenstein, S., Elliott, M., Colopy, M., & Schweinle, J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3243 · Cited by 752
Vaccines for preventing influenza in the elderly
Demicheli, V., Jefferson, T., Di Pietrantonj, C., Ferroni, E., Thorning, S., Thomas, R. E., & Rivetti, A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004876.pub4 · Cited by 695
Kaiser, L., Wat, C., Mills, T., Mahoney, P., Ward, P., & Hayden, F. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.14.1667 · Cited by 501
Influenza and the Winter Increase in Mortality in the United States, 1959-1999
Reichert, T. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh227 · Cited by 451
Early administration of oral oseltamivir increases the benefits of influenza treatment
Aoki, F. Y. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg007 · Cited by 424
Nichols, W. G., Guthrie, K. A., Corey, L., & Boeckh, M. (2004) · Clinical Infectious Diseases · doi:10.1086/425004 · Cited by 377
Cooper, N. J., Sutton, A. J., Abrams, K. R., Wailoo, A., Turner, D., & Nicholson, K. G. (2003) · BMJ · doi:10.1136/bmj.326.7401.1235 · Cited by 357
Predicting Influenza Infections during Epidemics with Use of a Clinical Case Definition
Boivin, G., Hardy, I., Tellier, G., & Maziade, J. (2000) · Clinical Infectious Diseases · doi:10.1086/317425 · Cited by 347
The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines
Nichol, K. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00070-7 · Cited by 265
Predicting Antimicrobial Resistance in Invasive Pneumococcal Infections
Vanderkooi, O. G., Low, D. E., Green, K., Powis, J. E., McGeer, A., & for the Toronto Invasive Bacterial Disease Network (2005) · Clinical Infectious Diseases · doi:10.1086/429242 · Cited by 257
Self-citationRuest, A., Michaud, S., Deslandes, S., & Frost, E. H. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3487-3493.2003 · Cited by 186
Klimov, A. I., Rocha, E., Hayden, F. G., Shult, P. A., Roumillat, L. F., & Cox, N. J. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.5.1352 · Cited by 177
Impact of Rapid Diagnosis on Management of Adults Hospitalized With Influenza
Falsey, A. R., Murata, Y., & Walsh, E. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.4.ioi60207 · Cited by 158
Macrolide Resistance in Bacteremic Pneumococcal Disease: Implications for Patient Management
McGeer, A., Green, A. K., Low, D. E., & Toronto Invasive Bacterial Diseases Network (2006) · Clinical Infectious Diseases · doi:10.1086/505871 · Cited by 153
Self-citationMonto, A. S., Webster, A., & Keene, O. N. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.suppl_2.23 · Cited by 153
Maciosek, M. V., Solberg, L. I., Coffield, A. B., Edwards, N. M., & Goodman, M. J. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.03.008 · Cited by 151
Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999–2000
Bowles, S. K., Lee, W., Simor, A. E., Vearncombe, M., Loeb, M. B., Tamblyn, S. E., Fearon, M. A., Li, Y., McGeer, A., & The Oseltamivir Compassionate Use Program Group (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50153.x · Cited by 143
Self-citationThe role of antivirals in the control of influenza
Monto, A. S. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00075-6 · Cited by 121
Safety and Efficacy of Nebulized Zanamivir in Hospitalized Patients with Serious Influenza
NIAID Collaborative Antiviral Study Group, Ison, M. G., Gnann, J. W., Nagy-Agren, S. E., Treanor, J. J., Payá, C. V., Steigbigel, R. T., Elliott, M. J., Weiss, H. L., & Hayden, F. G. (2003) · Antiviral Therapy · doi:10.1177/135965350300800301 · Cited by 118
Factors Associated with Early Hospital Discharge of Adult Influenza Patients
Lee, N. L. S., Chan, P. K. S., Choi, K., Lui, G. C.-Y., Wong, B. C. K., Cockram, C. S., Hui, D. S. C., Lai, R. W. M., Tang, J. W.-T., & Sung, J. J. �. (2007) · Antiviral Therapy · doi:10.1177/135965350701200408 · Cited by 114
Loughlin, J. E., Poulios, N., Napalkov, P., ller, Y. W., & Monto, A. S. (2003) · PharmacoEconomics · doi:10.2165/00019053-200321040-00005 · Cited by 61
Nordstrom, B. L., Sung, I., Suter, P., & Szneke, P. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x46214 · Cited by 60
Gillissen, A., & Höffken, G. (2002) · Medical Microbiology and Immunology · doi:10.1007/s00430-002-0139-9 · Cited by 25
Cited by
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657
Bradley, J. S., Byington, C. L., Shah, S. S., Alverson, B., Carter, E. R., Harrison, C., Kaplan, S. L., Mace, S. E., McCracken, G. H., Moore, M. R., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir531 · Cited by 1,919
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009
Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906695 · Cited by 1,700
Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
Siston, A. M. (2010) · JAMA · doi:10.1001/jama.2010.479 · Cited by 1,034
Louie, J. K. (2009) · JAMA · doi:10.1001/jama.2009.1583 · Cited by 1,019
Metadata
- Authors
- McGeer, A., Green, K. A., Plevneshi, A., Shigayeva, A., Siddiqi, N., Raboud, J., Low, D. E., & Toronto Invasive Bacterial Diseases Network
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12-15
- Volume
- 45
- Issue
- 12
- Pages
- 1568-1575
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W1971662199
- Cited by
- 398
- References
- 30
- FWCI
- 24.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.